Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells

Drug Metabolism and Disposition

Volumn 35, Issue 4, 2007, Pages 676-681

  Roychowdhury, Sanjoy ^a,c   Vyas, Piyush M ^a,d   Svensson, Craig K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b PURDUE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DRUG METABOLITE; N HYDROXYDAPSONE; SULFAMETHOXAZOLE; SULFAMETHOXAZOLE HYDROXYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG METABOLISM; DRUG PROTEIN BINDING; HAPTEN CARRIER COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT;

BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CELL DIFFERENTIATION; CELL LINE; DAPSONE; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAPTENS; HUMANS; MICROSCOPY, CONFOCAL; OXYGENASES; PEROXIDASE; PROTEIN BINDING; PROTEINS; SERUM ALBUMIN, BOVINE; SULFAMETHOXAZOLE; TIME FACTORS;

BOVINAE;

EID: 34047101360     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.013680     Document Type: Article

References (30)

1. Ackerman AL and Cresswell P (2003) Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J Immunol 170:4178-4188.
2. Ardavin C, Martinez del Hoyo G, Martin P, Anjuere F, Arias CF, Marin AR, Ruiz S, Parrillas V, and Hernandez H (2001) Origin and differentiation of dendritic cells. Trends Immunol 22:691-700.
3. Berges C, Naujokat C, Tinapp S, Wieczorek H, Hoh A, Sadeghi M, Opelz G, and Daniel V (2005) A cell line model for the differentiation of human dendritic cells. Biochem Biophys Res Commun 333:896-907.
4. Bhaiya P, Roychowdhury S, Vyas PM, Doll MA, Hein DW, and Svensson CK (2006) Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts. Toxicol Appl Pharmacol 215:158-167.
5. Bracho F, van de Ven C, Areman E, Hughes RM, Davenport V, Bradley MB, Cai JW, and Cairo MS (2003) A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCs. Cytotherapy 5:349-361.
6. Goebel C, Vogel C, Wulferink M, Mittmann S, Sachs B, Schraa S, Abel J, Degen G, Uetrecht J, and Gleichmann E (1999) Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages. Chem Res Toxicol 12:488-500.
7. Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B, Kappeler A, von Greyerz S, Braathen LR, and Pichler WJ (2001) T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 31:1398-1408.
8. Herrmann TL, Morita CT, Lee K, and Kusner DJ (2005) Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells. J Leukocyte Biol 78:1397-1407.
9. Hulette BC, Rowden G, Ryan CA, Lawson CM, Dawes SM, Ridder GM, and Gerberick GF (2001) Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype. Arch Dermatol Res 293:147-158.
10. Jakob T, Ring J, and Udey MC (2001) Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 108:688-696.
11. Koeffler HP and Golde DW (1978) Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science (Wash DC) 200:1153-1154.
12. Manchanda T, Hess D, Dale L, Ferguson SG, and Rieder MJ (2002) Haptenation of sulfonamide reactive metabolites to cellular proteins. Mol Pharmacol 62:1011-1026.
13. Norgauer J, Ibig Y, Gmeiner D, Herouy Y, and Fiebich BL (2003) Prostaglandin E2 synthesis in human monocyte-derived dendritic cells. Int J Mol Med 12:83-86.
14. O'Neill HC and Wilson HL (2004) Limitations with in vitro production of dendritic cells using cytokines. J Leukoc Biol 75:600-603.
15. Reid CD, Fryer PR, Clifford C, Kirk A, Tikerpae J, and Knight SC (1990) Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood 76:1139-1149.
16. Reilly TP, Lash LH, Doll MA, Hein DW, Woster PM, and Svensson CK (2000) A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Investig Dermatol 114:1164-1173.
17. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, and Schuler G (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83-93.
18. Roychowdhury S and Svensson CK (2005) Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J 7:E834-E846.
19. Roychowdhury S, Vyas PM, Reilly TP, Gaspari AA, and Svensson CK (2005) Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J Pharmacol Exp Ther 314:43-52.
20. Saeki M, Saito Y, Nagano M, Teshima R, Ozawa S, and Sawada J (2002) mRNA expression of multiple cytochrome P450 isozymes in four types of cultured skin cells. Int Arch Allergy Immunol 127:333-336.
21. Sanderson JP, Naisbitt DJ, and Park BK (2006) Role of bioactivation in drug-induced hypersensitivity reactions. AAPS J 8:E55-64.
22. Santiago-Schwarz F, Belilos E, Diamond B, and Carsons SE (1992) TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 52:274-281.
23. Sieben S, Baron JM, Blomeke B, and Merk HF (1999) Multiple cytochrome P450-isoenzymes mRNA are expressed in dendritic cells. Int Arch Allergy Immunol 118:358-361.
24. St Louis DC, Woodcock JB, Franzoso G, Blair PJ, Carlson LM, Murillo M, Wells MR, Williams AJ, Smoot DS, Kaushal S, et al. (1999) Evidence for distinct intracellular signaling pathways in CD34 progenitor to dendritic cell differentiation from a human cell line model. J Immunol 162:3237-3248.
25. Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, Bursch L, Ronchese F, and Romani N (2006) Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 103:7783-7788.
26. Strobl H, Takimoto M, Majdic O, Fritsch G, Scheinecker C, Hocker P, and Knapp W (1993) Myeloperoxidase expression in CD34 normal human hematopoietic cells. Blood 82:2069-2078.
27. Svensson CK, Cowen EW, and Gaspari AA (2001) Cutaneous drug reactions. Pharmacol Rev 53:357-379.
28. Vyas PM, Roychowdhury S, Woster PM, and Svensson CK (2005) Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes. Biochem Pharmacol 70:275-286.
29. Vyas PM, Roychowdhury S, Khan FD, Prisinzano TE, Lamba JK, Schuetz EG, Blaisdell J, Goldstein JA, Munson KL, Hines RN, et al. (2006a) Enzyme-mediated protein haptenation of dapsone and sulfamethoxaozle in human keratinocytes: I. Expression and role of cytochromes P450. J Pharmacol Exp Ther 319:488-496.
30. Vyas PM, Roychowdhury S, Koukouritaki SB, Hines RN, Krueger SK, Williams DE, Nauseef WM, and Svensson CK (2006b) Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygeanses and peroxidases. J Pharmacol Exp Ther 319:497-505.